Literature DB >> 32124179

Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need.

Tengyue Zhang1, Yudi He2, Wenshuai Xu2, Aiping Ma3, Yanli Yang2, Kai-Feng Xu4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32124179      PMCID： PMC7089458          DOI： 10.1007/s11427-020-1660-2

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   6.038


× No keyword cloud information.
Table S1. Therapeutic approaches in registered clinical trials on coronavirus disease 2019 (COVID-19)
  3 in total

1.  More than 80 clinical trials launch to test coronavirus treatments.

Authors:  Amy Maxmen
Journal:  Nature       Date:  2020-02       Impact factor: 49.962

2.  Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.

Authors:  K S Chan; S T Lai; C M Chu; E Tsui; C Y Tam; M M L Wong; M W Tse; T L Que; J S M Peiris; J Sung; V C W Wong; K Y Yuen
Journal:  Hong Kong Med J       Date:  2003-12       Impact factor: 2.227

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321
  3 in total
  14 in total

Review 1.  The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19).

Authors:  Mojgan Sheikhpour
Journal:  Ther Clin Risk Manag       Date:  2020-10-07       Impact factor: 2.423

Review 2.  Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.

Authors:  Osama A Badary; Marwa S Hamza; Rajiv Tikamdas
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

Review 3.  Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options.

Authors:  Boxuan Huang; Rongsong Ling; Yifan Cheng; Jieqi Wen; Yarong Dai; Wenjie Huang; Siyan Zhang; Xifeng Lu; Yifeng Luo; Yi-Zhou Jiang
Journal:  Mol Ther Methods Clin Dev       Date:  2020-06-24       Impact factor: 6.698

4.  Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis.

Authors:  Yi Zhou; Liyu Chen
Journal:  Int J Environ Res Public Health       Date:  2020-04-28       Impact factor: 3.390

5.  Evaluating the Efficacy and Safety of the Existing Repurposed Pharmacological Agents for Treating COVID-19: A Meta-analysis and Systematic Review of Clinical Trials.

Authors:  Nang S Choupoo; Saurabh K Das; Rudrashish Haldar; Hillol Sarkar; Resma Tewari; Sumit Ray
Journal:  Indian J Crit Care Med       Date:  2020-11

Review 6.  Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19).

Authors:  Yavuz Nuri Ertas; Mahboobeh Mahmoodi; Fahimeh Shahabipour; Vahid Jahed; Sibel Emir Diltemiz; Rumeysa Tutar; Nureddin Ashammakhi
Journal:  Emergent Mater       Date:  2021-03-16

7.  Knowledge, Attitudes, and Practices Regarding COVID-19 among Healthcare Workers in Uganda: A Cross-Sectional Survey.

Authors:  Onesmus Kamacooko; Jonathan Kitonsa; Ubaldo M Bahemuka; Freddie M Kibengo; Anne Wajja; Vincent Basajja; Alfred Lumala; Ayoub Kakande; Paddy Kafeero; Edward Ssemwanga; Robert Asaba; Joseph Mugisha; Benjamin F Pierce; Robin J Shattock; Pontiano Kaleebu; Eugene Ruzagira
Journal:  Int J Environ Res Public Health       Date:  2021-06-30       Impact factor: 3.390

Review 8.  COVID-19 diagnosis and management: a comprehensive review.

Authors:  Giuseppe Pascarella; Alessandro Strumia; Chiara Piliego; Federica Bruno; Romualdo Del Buono; Fabio Costa; Simone Scarlata; Felice Eugenio Agrò
Journal:  J Intern Med       Date:  2020-05-13       Impact factor: 13.068

Review 9.  The upshot of Polyphenolic compounds on immunity amid COVID-19 pandemic and other emerging communicable diseases: An appraisal.

Authors:  Ayman Khalil; Diana Tazeddinova
Journal:  Nat Prod Bioprospect       Date:  2020-10-15

Review 10.  SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention.

Authors:  Alessio Danilo Inchingolo; Angelo Michele Inchingolo; Ioana Roxana Bordea; Giuseppina Malcangi; Edit Xhajanka; Antonio Scarano; Felice Lorusso; Marco Farronato; Gianluca Martino Tartaglia; Ciro Gargiulo Isacco; Grazia Marinelli; Maria Teresa D'Oria; Denisa Hazballa; Luigi Santacroce; Andrea Ballini; Maria Contaldo; Francesco Inchingolo; Gianna Dipalma
Journal:  Microorganisms       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.